Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
J Cancer Res Clin Oncol ; 149(11): 8393-8402, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37079052

ABSTRACT

PURPOSE: For patients with a cancer diagnosis, coping abilities are of high importance. Cancer patients with a high sense of coherence may cope better. The purpose of this study is to learn more about the correlation of sense of coherence and different aspects, such as demographics, psychological factors, lifestyle, complementary and alternative medicine (CAM) and lay aetiology. METHODS: A prospective cross-sectional study was performed in ten cancer centres in Germany. The questionnaire consisted of ten sub-items, collecting information about sense of coherence, demographics, general life satisfaction, resilience, spirituality, self-efficacy, physical activity and sports, nutrition, CAM methods and cancer causes. RESULTS: As many as 349 participants were evaluable. The mean sense of coherence score was M = 47.30. Significant associations were shown for sense of coherence and financial situation (r = 0.230, p < 0.001), level of education (r = 0.187, p < 0.001), marital status (η = 0.177, p = 0.026) and time interval since diagnosis (r = - 0.109, p = 0.045). Sense of coherence and resilience correlated on a high level, as well as spirituality, self-efficacy and general life satisfaction (r = 0.563, r = 0.432, r = 0.461, r = 0.306, p's < 0.001). CONCLUSION: Several aspects, such as demographics and psychological factors, have a great influence on the sense of coherence. To help patients to cope better, physicians should try to strengthen sense of coherence, resilience and self-efficacy and, at the same time, consider patients' individual background such as level of education, financial capacity and emotional support by family members.


Subject(s)
Complementary Therapies , Sense of Coherence , Humans , Cross-Sectional Studies , Prospective Studies , Quality of Life/psychology , Life Style , Surveys and Questionnaires
2.
Inn Med (Heidelb) ; 64(1): 3-9, 2023 Jan.
Article in German | MEDLINE | ID: mdl-36594968

ABSTRACT

BACKGROUND: Approximately half of all cancer patients use complementary or alternative medicine. AIM: The results of the German S3 guidelines on complementary oncology are presented and placed into the context of patient consultation. MATERIAL AND METHODS: The core recommendations of the S3 guidelines are summarized including an overview of the evidence. RESULTS: Selected methods of complementary medicine can be used with the aim of improving the quality of life and reducing side effects. Comprehensive data are available for physical activity with respect to survival, quality of life and supportive therapy. For most other methods the evidence is relatively low. Therefore, weighing up the benefits and risks more frequently resulted in negative recommendations in the guidelines, especially for methods based on substances. Exceptions to this are three micronutrients (vitamins B12, D and selenium), as even in the case of a well-balanced diet, deficiency symptoms are possible. Therefore, routine measurement of the blood levels of these micronutrients is recommended. CONCLUSION: The questions from patients on what they can do by themselves should be answered respectfully and based on evidence. The benefits and risks of complementary methods must be carefully considered. To do this, regular questioning of patients on the interest in complementary methods is recommended. The decisive benefit of complementary medicine is the chance for patients to become active themselves. Therefore, all recommendations refer to the discussion with the patient, which do not formulate a therapy but are consultation recommendations: should be recommended instead of should be done.


Subject(s)
Complementary Therapies , Neoplasms , Humans , Quality of Life , Complementary Therapies/adverse effects , Medical Oncology , Neoplasms/therapy , Micronutrients
3.
J Cancer Res Clin Oncol ; 149(9): 6067-6074, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36653538

ABSTRACT

BACKGROUND: The usage of complementary and alternative medicine (CAM) is widespread among cancer patients. While reasons for and aims of using CAM have been evaluated in many studies, less is known about whether patients' concepts of how and why cancer develops has an influence on the choice of the CAM method. METHODS: We pooled the data from all studies of our working group containing questions on lay etiological concepts and CAM usage and reanalyzed them with respect to the associations between these parameters. RESULTS: The pooled dataset from 12 studies included 4792 patients. A third (1645 patients) reported using CAM. Most often used were supplements (55.9%), relaxation techniques (43.6%), and homeopathy (37.9%). Regarding perceived causes, patients most often marked stress (35.4%) followed by genes (31.9%). While all lay etiological beliefs were highly significantly associated with usage of CAM in general, there was no association between single lay etiological concepts and types of CAM used. Yet, in a network analysis, we found two associations: one comprising trauma, mistletoe, genes, and nutritional supplements, the other yoga, vitamin C, nutritional supplements, and TCM herbs. In the correlation heatmap, one cluster comprises etiological concepts of personality, immune system and trauma, and two clusters of CAM methods emerged: one comprising praying, yoga, meditation, and relaxation procedures, the other nutritional supplements, selenium, vitamins A and C. CONCLUSION: While physicians are trained to derive treatment strategies from etiological concepts, lay people choosing CAM do not follow these rules, which may point to other needs of patients addressed by CAM.


Subject(s)
Complementary Therapies , Neoplasms , Physicians , Humans , Complementary Therapies/methods , Mind-Body Therapies , Neoplasms/etiology , Neoplasms/therapy , Dietary Supplements , Vitamins , Surveys and Questionnaires
4.
Nutr Cancer ; 75(1): 33-47, 2023.
Article in English | MEDLINE | ID: mdl-35819060

ABSTRACT

B-vitamins act as enzymatic co-factors in immune functions, therefore they are considered to reduce chemotherapy-induced side effects in cancer patients. We conducted a systematic search, screening five electronic databases (Embase, Cochrane, PsychInfo, CINAHL and Medline) to find studies on the effectiveness and potential harm of B-vitamin therapy on cancer patients. Out of the 7465 search results, 11 RCTs about vitamin B6, B12 and B-vitamins in combination were included in this systematic review. A total of 1546 patients with diverse types of cancer were evaluated. Overall, most studies were of acceptable quality and reported consistent results. Studies examining the effectiveness of vitamin B6 reported that there is no significant impact on decreasing the incidence and severity of chemotherapy-induced side effects (e.g., hand-foot syndrome), the necessity of chemotherapy dose-modifications or improving patients' quality of life, tumor response/progression, and overall survival. Two studies reported that vitamin B12 could be effective in the alleviation of symptoms resulting from chemotherapy; it might decrease motor, sensory and pain symptoms of peripheral neuropathy. However, a combination of B vitamins may not reduce the incidence of chemotherapy-induced peripheral neuropathy. All in all, the evidence on B-vitamins in cancer patients is low and supplementation cannot be recommended.


Subject(s)
Antineoplastic Agents , Neoplasms , Peripheral Nervous System Diseases , Vitamin B Complex , Humans , Vitamin B Complex/therapeutic use , Quality of Life , Dietary Supplements , Vitamin B 6/therapeutic use , Neoplasms/drug therapy , Antineoplastic Agents/adverse effects
5.
Clin Exp Med ; 21(2): 297-313, 2021 May.
Article in English | MEDLINE | ID: mdl-33496846

ABSTRACT

Zinc is a trace element that plays an important role in the immune system and cell growth. The role of zinc in cancer treatment has been discussed for some time, however without reaching an evidenced-based consensus. Therefore, we aim to critically examine and review existing evidence on the role of zinc during cancer treatment. In January 2019, a systematic search was conducted searching five electronic databases (Embase, Cochrane, PsychINFO, CINAHL and PubMed) to find studies concerning the use, effectiveness and potential harm of zinc therapy on cancer patients. Out of initial 5244 search results, 19 publications concerning 23 studies with 1230 patients were included in this systematic review. The patients treated with zinc were mainly diagnosed with head and neck cancer and underwent chemo-, radio- or concurrent radio-chemotherapy. Interventions included the intake of different amounts of zinc supplements and oral zinc rinses. Outcomes (primary endpoints) investigated were mucositis, xerostomia, dysgeusia, pain, weight, dermatitis and oral intake of nutrients. Secondary endpoints were survival data, quality of life assessments and aspects of fatigue, immune responses and toxicities of zinc. The studies were of moderate quality reporting heterogeneous results. Studies have shown a positive impact on the mucositis after radiotherapy. No protection was seen against mucositis after chemotherapy. There was a trend to reduced loss of taste, less dry mouth and oral pain after zinc substitution. No impact was seen on weight, QoL measurements, fatigue, and survival. The risk of side effects from zinc appears to be relatively small. Zinc could be useful in the prevention of oral toxicities during irradiation. It does not help in chemotherapy-induced side effects.


Subject(s)
Complementary Therapies , Neoplasms/drug therapy , Zinc/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Dysgeusia/drug therapy , Female , Humans , Male , Middle Aged , Mucositis/drug therapy , Neoplasms/mortality , Neoplasms/psychology , Quality of Life , Xerostomia/drug therapy , Young Adult , Zinc/adverse effects
6.
HNO ; 69(11): 878-885, 2021 Nov.
Article in German | MEDLINE | ID: mdl-33052423

ABSTRACT

BACKGROUND AND OBJECTIVE: Laryngectomy is usually associated with olfactory dysfunction. How do laryngectomees personally experience and feel about this change? MATERIALS AND METHODS: In cooperation with the Bundesverband der Kehlkopfoperierten (German Association of Throat Cancer Patients) and together with laryngectomized patients, a new questionnaire was created and distributed via the regional offices according to the population sizes of the federal states (n = 293) for the first time in spring 2018. The questionnaire covers patient characteristics and daily life without a larynx, as well as the specific areas of smell and taste, albeit without differentiation between ortho- and retronasal olfaction. The items were designed to be answered using patient-friendly visual rating scales, multiple-choice answers, and free text. RESULTS: Return rate was 198/293 (67.6%). Median age of all participants was 69 years (48-88). Overall life situation was rated by 99/198 (50%) participants as "good" or "very good." The primary subjective impairment for the patients was loss of voice (137/198, 69.1%) and loss of olfaction (113/198, 59.1%). Adaption to life without a larynx has been completed within a maximum of 3 years for 161/198 (81.3%) patients. Principally, 127/198 (64.1%) affirmed being able to smell and 176 of 198 (88.9%) being able to taste; however, only 29/198 (14.6%) rated their sense of smell and 109/198 (55.1%) their sense of taste as "good" or "very good." Most frequently detected smell sensations were perfume (141), smoke (126), and feces (99). Univariate analysis showed a significant (p < 0.05) correlation between adaptation time <1 year and current subjective smell and taste. CONCLUSION: Subjective loss of smell and taste after laryngectomy is a daily problem for patients in Germany, which should be focused on promptly and included in early rehabilitation strategies.


Subject(s)
Larynx , Olfaction Disorders , Aged , Aged, 80 and over , Humans , Laryngectomy , Middle Aged , Olfaction Disorders/diagnosis , Olfaction Disorders/epidemiology , Olfaction Disorders/etiology , Smell , Surveys and Questionnaires
7.
HNO ; 68(7): 483-491, 2020 Jul.
Article in German | MEDLINE | ID: mdl-32130458

ABSTRACT

Nutrition remains a relevant issue until the end of life, both for patients and their relatives. This is particularly true for palliative patients with advanced head and neck cancer. In addition to local problems caused by the disease and its treatment, patients suffer from social aspects such as isolation, decreasing strength, and reduced mobility. Effective nutritional counselling and therapy are necessary to retain quality of life and self-care for as long as possible. Dialogue between the palliative care team and ENT oncologists should serve as the basis for developing an individual plan for each patient in this difficult situation. A special section of this manuscript focuses on the value of traditional herbal medicine for different ENT symptoms in the context of nutrition. The aim of this review is to promote qualified discussion between patient, relatives, and professionals.


Subject(s)
Head and Neck Neoplasms , Neoplasms , Nutritional Support , Palliative Care , Delivery of Health Care , Humans , Quality of Life
8.
Cancer Invest ; 37(4-5): 216-226, 2019.
Article in English | MEDLINE | ID: mdl-31204520

ABSTRACT

This survey aimed at getting a first insight into diverse side effects and their association with satisfaction with life as well as the use of complementary and alternative medicine (CAM) in cancer patients. A total of 100 patients in a German University Hospital were included. General side effects like fatigue, fever, headache, limb pain and sleep disorders had a significant influence on the patients' satisfaction with life (p = .034 and p = .032, respectively). Concerning CAM, we could not detect any association between the frequency of side effects and the use of CAM. Improving the treatment of side effects may have a strong impact on patients' satisfaction with life.


Subject(s)
Complementary Therapies/statistics & numerical data , Neoplasms/therapy , Patient Satisfaction , Quality of Life , Adult , Aged , Complementary Therapies/methods , Female , Germany , Humans , Male , Middle Aged , Neoplasms/psychology , Patient-Centered Care/methods , Pilot Projects , Surveys and Questionnaires/statistics & numerical data , Treatment Outcome
9.
Med Oncol ; 33(7): 78, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27300549

ABSTRACT

Complementary and alternative medicine (CAM) is widely used by cancer patients. In order to learn more on the usage of CAM, its reasons and motifs as well as sources of information along the trajectory of treatment, we decided to evaluate the prevalence and predictors for the use of CAM by cancer patients while being under active treatment with chemo- or radiotherapy or in aftercare. We distributed a standardized questionnaire among patients attending a department of radio-oncology, an ambulance for oncology and offices of general practitioners (GPs). Five hundred and six patients took part. Most attributed cancer to stress and trauma (23.7 and 16.4 %) or genes (20.8 %). Forty-four percentage reported knowing a physician with competence in CAM, and in all settings, most patients named the GP. Fifty-one percentage admitted using CAM, 35 % informed the oncologist about using CAM, 56 % informed the GP, and 26 % did not inform any physician. Most often used CAM was vitamin D (17 %) and selenium (16 %). Most important goals were to strengthen the immune system (59 %) and become active (52 %). Most patients were satisfied with the CAM methods they used. Yet, with some methods, dissatisfaction was up to 30 %. The GP has an important function concerning CAM in oncology as most patients believe the GP to have best knowledge in CAM. In order to integrate complementary medicine into evidence-based medicine, physicians should be trained on how to communicate on CAM with the patient and with each other. Explaining cancer and cancer therapies in a way lay persons are able to understand may be helpful. Physicians should actively address patients' needs of involvement not only in decision making, but also actively in the therapy.


Subject(s)
Complementary Therapies/statistics & numerical data , Health Knowledge, Attitudes, Practice , Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Patient Satisfaction , Surveys and Questionnaires
10.
HNO ; 62(5): 335-41, 2014 May.
Article in German | MEDLINE | ID: mdl-24718562

ABSTRACT

The aim of palliative care is to improve the quality of life (QOL) of patients with a limited life expectancy in a comprehensive multidisciplinary approach. It encompasses consideration of medical, physical, psychosocial and spiritual problems, including treatment and help from a team of various professionals. Palliative care often extents to the patient's families and may continue after the death of the patient. Half of all head and neck cancer patients will die of their malignancy within 5 years of diagnosis. The primary medical issues affecting QOL at the end of life are communication problems due to laryngectomy or tracheostomy, disturbed eating and drinking due to surgery and radiotherapy, edematous changes of the face and neck with resultant functional and cosmetic consequences, as well as strong-smelling ulcerated wounds, which often lead to social isolation. General symptoms occurring at the end of life include pain, anxiety, different types of dyspnea and acute bleeding. All therapeutic approaches applied during the last phase of life must be questioned regarding their real efficacy and side effects. Consideration of the patient's wishes is of the highest priority.


Subject(s)
Head and Neck Neoplasms/psychology , Head and Neck Neoplasms/therapy , Palliative Care/methods , Palliative Care/psychology , Quality of Life/psychology , Terminal Care/methods , Terminal Care/psychology , Germany , Head and Neck Neoplasms/diagnosis , Humans , Treatment Outcome
11.
Laryngorhinootologie ; 91(7): 434-9, 2012 Jul.
Article in German | MEDLINE | ID: mdl-22407511

ABSTRACT

BACKGROUND: Although modern minimal-invasive paranasal sinus surgery is an integral part of clinical routine of otorhinolaryngologic surgeons, there are no population-based data on incidence and efficiency of this surgery published. MATERIAL AND METHODS: 1,582 patients underwent paranasal sinus surgery in the 8 Thuringian departments of otorhinolaryngology in 2005. All patients were analysed regarding patients' characteristics, therapy, complications and further course of disease. RESULTS: The incidence of paranasal sinus surgery was 46/100,000 for women and higher for men with 72/100,000. Median age was 48 years. Chronic sinusitis was the main reason for surgery (94%; including 33% with nasal polyps) and was performed dominantly as endoscopic sinus surgery (96%). Surgery was performed bilaterally in 75% of the cases and as primary surgery. In most cases at least 2 paranasal sinuses per side were approached. Relevant complications were observed in 4% of patients. During the follow-up time of 45-51 months a recurrence was observed in 9% of cases. Using a multivariate regression analysis, revision surgery, allergic subject and diagnosis of a malignant tumor were significant independent risk factors to predict a recurrence. Older age and longer time of surgery were significant independent risk factors for a complication. CONCLUSION: This population based analysis is showing that modern paranasal sinus surgery is performed in high incidence, effectively and with low-risk on a large scale in daily routine of rhinologic surgeons.


Subject(s)
Endoscopy/statistics & numerical data , Health Services Research/statistics & numerical data , Minimally Invasive Surgical Procedures/statistics & numerical data , Nasal Polyps/epidemiology , Nasal Polyps/surgery , Paranasal Sinus Neoplasms/epidemiology , Paranasal Sinus Neoplasms/surgery , Paranasal Sinuses/injuries , Sinusitis/epidemiology , Sinusitis/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Ambulatory Surgical Procedures/statistics & numerical data , Child , Child, Preschool , Cross-Sectional Studies , Female , Germany , Humans , Infant , Male , Middle Aged , Paranasal Sinuses/surgery , Postoperative Complications/etiology , Postoperative Complications/surgery , Reoperation , Retrospective Studies , Treatment Outcome , Utilization Review/statistics & numerical data , Young Adult
12.
HNO ; 59(11): 1139-47; quiz 1148-9, 2011 Nov.
Article in German | MEDLINE | ID: mdl-22012488

ABSTRACT

Tumours of the upper aerodigestive tract cause malnutrition in the majority of ENT cancer patients. This situation is complicated by multimodal treatment regimens (including surgery and/or irradiation). The resulting malnutrition is a disease entity in its own right and requires special treatment concepts. Effective screening tools (NRS 2002) need to be introduced and data such as body mass index and bioimpedance analysis need to be gathered. The nutrition plan for individual ENT patients differs according to the grade of malnutrition and dysphagia. Oral nutrition should always form the basis of any nutrition programme, such that logopedic therapy is required in all cases of dysphagia. Artifical, oral high-energy nutrition is a pharmacological procedure as well as enteral feeding via PEG or PEJ. Partial or total parenteral nutrition (central venous access) should be restricted to crisis interventions or fast-track regimens.


Subject(s)
Diet Therapy/methods , Nutrition Disorders/etiology , Nutrition Disorders/therapy , Nutritional Support/methods , Otorhinolaryngologic Neoplasms/complications , Otorhinolaryngologic Neoplasms/therapy , Humans
13.
Anticancer Res ; 30(5): 1829-32, 2010 May.
Article in English | MEDLINE | ID: mdl-20592387

ABSTRACT

OBJECTIVE: The substitution of selenium activates the selenium-dependent enzyme glutathione peroxidase, which is important for scavenging free radicals. To date, only limited data are available about the clinical impact of selenium regarding the toxicities due to free radical producing therapies, e.g. irradiation or chemotherapy, and therefore the objective of this study was to investigate the clinical impact of selenium in such therapies. PATIENTS AND METHODS: 39 patients (8 female, 31 male) with advanced head and neck cancer were included in a randomised phase II study. The mean age was 63.52+/-9.31 years. Tumour localizations: oral cavity 15 patients, oropharynx 19 patients, hypopharynx 5 patients, carcinoma of unknown primary 1 patient. Group A (n=22) received 500 microg sodium selenite on the days of radiotherapy and 300 microg sodium selenite on days without radiotherapy. Group B (17) was irradiated without any selenium substitution. Both groups were well balanced according to age, gender, localization and stage of the tumour. The RTOG grade of radiation-associated toxicities was evaluated once per week. RESULTS: The following serious toxicities were observed (group A vs. group B): dysphagia 22.7% vs. 35.3%, loss of taste 22.7% vs. 47.1%, dry mouth 22.7% vs. 23.5%, and stomatitis 36.4% vs. 23.5%. A statistical trend (Fisher's exact test) was only seen for the loss of taste (p=0.172). The weekly patient analysis (Student's t-test) showed a significant reduction of dysphagia in the selenium group (Group 1) at the last week of irradiation. CONCLUSION: This small randomised trial showed limited effects of selenium in the prevention of ageusia (loss of taste) and dysphagia due to radiotherapy of head and neck cancer.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/radiotherapy , Radiation Injuries/pathology , Radiation Injuries/prevention & control , Sodium Selenite/pharmacology , Aged , Deglutition Disorders/pathology , Deglutition Disorders/prevention & control , Female , Humans , Male , Medical Oncology/methods , Middle Aged , Mucositis/prevention & control , Xerostomia/prevention & control
14.
Front Radiat Ther Oncol ; 42: 198-205, 2010.
Article in English | MEDLINE | ID: mdl-19955808

ABSTRACT

Study on the use of complementary and alternative medicine (CAM) in lung cancer patients has been widely neglected. Therefore, we initiated a study on the use of CAM in lung cancer patients in addition to radiation treatment. Overall, 120 patients from 3 institutions were interviewed by a standardized questionnaire. Besides the tumor parameters and the use of CAM, the reason for the use, patient information of the medication, the information sources and the subjective condition of the patient. Altogether, 54% of the patients reported using CAM (66% of female patients, 52% of male patients). The most frequently used CAM measures were vitamin combinations (17%), mistletoe (15%), and selenium (12%). A total of 52% reported the wish to support the tumor treatment as a reason for using CAM and 27% had a 'better feeling' using CAM. 50% of CAM was bought by the patients themselves and 50% were prescribed by their family physicians. The use of CAM is frequent in lung cancer patients. Our results suggest that it is very important to obtain information on the CAM use of patients and, particularly in controlled clinical trials, to prospectively document it.


Subject(s)
Carcinoma, Non-Small-Cell Lung/therapy , Complementary Therapies , Lung Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Carcinoma, Non-Small-Cell Lung/pathology , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging
16.
Laryngorhinootologie ; 86(9): 660-3, 2007 Sep.
Article in German | MEDLINE | ID: mdl-17219339

ABSTRACT

OBJECTIVE: The otogenic brain abscess remains a serious intracranial complication of otitis media despite advantages in diagnostics and antibiotic treatment during the last decades. We discuss the clinical picture and the possible ways of treatment by the example of two case histories. CASE HISTORIES: Case 1: We report about a 38-year-old man, who was suffering in cholsteatoma since 30 years. The surgical revision was restricted by the patient since this time. The acute symptoms of meningitis were caused by intracranial involvement and cerebellar abscess due to cholesteatoma. After surgical revision we observed a period of clinical improvement. A repeated surgery became necessary because of renewed brain abscess at the cerebellar region five weeks after primary operation. Case 2: A 6-year-old girl was already treated with antibiotics because of subacute mastoiditis since three weeks. She was entering the ENT department because of headache and otorrhoea. During mastoidectomy the bone destruction leads to a cerebellar abscess. The neurological symptoms were regredient immediately after the surgical revision. CONCLUSION: Both case histories underline the importance of cerebellar abscess as an intracranial complication of chronic otitis media. The neurologic symptoms and the CT-scan were essential for the exact diagnosis. The following treatment includes the surgical revision of the middle ear, the abscess-drainage as well as the lavage of the cavity with antibiotics.


Subject(s)
Brain Abscess/etiology , Cerebellar Diseases/etiology , Cholesteatoma, Middle Ear/complications , Mastoiditis/complications , Adult , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Brain Abscess/diagnostic imaging , Brain Abscess/drug therapy , Brain Abscess/surgery , Cerebellar Diseases/diagnostic imaging , Cerebellar Diseases/drug therapy , Cerebellar Diseases/surgery , Child , Cholesteatoma, Middle Ear/surgery , Drainage , Female , Follow-Up Studies , Humans , Male , Mastoiditis/surgery , Penicillin G/administration & dosage , Penicillin G/therapeutic use , Postoperative Complications , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
17.
Med Princ Pract ; 13(4): 185-90, 2004.
Article in English | MEDLINE | ID: mdl-15181321

ABSTRACT

OBJECTIVE: To investigate the impact of selenium in the treatment of lymphedema of the head and neck region after radiotherapy alone or in combination with surgery. SUBJECTS AND MATERIALS: Between June 1996 and June 2001 a total of 36 cancer patients (29 male, 7 female; median age 61 years) were treated with selenium for persistent, extensive or progressive lymphedema of the head and neck region. Twenty had interstitial endolaryngeal edema associated with stridor and dyspnea. All patients received 350 microg/m(2) body surface sodium selenite medication p.o. daily (total dose 50 microg per day) for a period of 4-6 weeks after radiotherapy. The optimal effect of the selenium treatment was assessed after 4 weeks of therapy using the Miller score system. A visual analogue scale on a scale of 0-10 was used to assess the patient's quality of life prior to and after selenium. RESULTS: 75% of the patients had an improvement of the Miller score of one stage or more. The self-assessment of quality of life using the visual analogue scale improved significantly after selenium treatment with a reduction of 4.4 points (p < 0.05). Of the 20 patients with endolaryngeal edema tracheostomy was not necessary in 13 patients (65%), but 5 and 2 received a temporary or permanent tracheostomy, respectively. No episode of erysipelas was observed in all study patients. CONCLUSION: Our results suggest a short positive effect of sodium selenite on secondary head and neck lymphedema caused by radiotherapy alone or in combination with surgery.


Subject(s)
Head and Neck Neoplasms/drug therapy , Lymphedema/drug therapy , Sodium Selenite/therapeutic use , Aged , Chemotherapy, Adjuvant , Female , Head and Neck Neoplasms/psychology , Head and Neck Neoplasms/radiotherapy , Humans , Lymphedema/psychology , Lymphedema/radiotherapy , Male , Middle Aged , Quality of Life
18.
Laryngorhinootologie ; 82(8): 573-7, 2003 Aug.
Article in German | MEDLINE | ID: mdl-12915990

ABSTRACT

BACKGROUND: The changed mineral status is well known in different tumor types. This phenomenon has influenced the redox potential of patients suffering from solid cancers. A prospective trial was conducted to evaluate the specifics for untreated head and neck cancer patients. MATERIAL AND METHODS: We included 100 patients with advanced squamous cell carcinoma of the head and neck region before each kind of treatment. Following serum-concentrations were measured by atom absorption spectrometry: selenium, copper, zinc, and ferrum. Additionally we evaluated the activity of glutathion peroxidase and the concentration of malondialdehyde of the serum. RESULTS: 66 % of all patients have shown a decreased serum-concentration of selenium. These patients were additionally characterized by decreased activities of endogenous glutathionperoxiase. A third of all patients had decreased zinc and iron levels. Copper was found enhanced in 30 %. In trend the malondialdehyde was increasing due to decreasing selenium levels. CONCLUSIONS: Head neck cancer patients show the same characteristic trace element status as other solid tumors: decreased selenium, zinc and iron, increased copper. The therapeutic consequences of these observations are still unclear.


Subject(s)
Carcinoma, Squamous Cell/blood , Otorhinolaryngologic Neoplasms/blood , Trace Elements/blood , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Combined Modality Therapy , Copper/blood , Female , Glutathione Peroxidase/blood , Humans , Iron/blood , Male , Malondialdehyde/blood , Middle Aged , Neoplasm Staging , Otorhinolaryngologic Neoplasms/drug therapy , Otorhinolaryngologic Neoplasms/pathology , Otorhinolaryngologic Neoplasms/radiotherapy , Reference Values , Selenium/blood , Selenium/deficiency , Zinc/blood
20.
Article in German | MEDLINE | ID: mdl-14707478

ABSTRACT

BACKGROUND: Complementary/alternative medicine (CAM) is gaining increasing importance especially in the treatment of patients with breast carcinoma. The purpose of this analysis was to investigate the prevalence of CAM in patients with breast carcinoma, to statistically describe the preparations and therapies used, and to determine the reasons for their use, the source of information and the individual perception. PATIENTS AND METHODS: The statements of 203 patients with breast carcinoma who underwent radiotherapy were analyzed. The median age was 54 years (range 38-77 years). All patients underwent surgery as first therapy. 36 patients received a second-line radiotherapy because of metastases (27 patients) or local recurrence (9 patients). RESULTS: 159 patients (78%) stated to carry out an additional treatment. 31 out of the 36 patients with metastases or local recurrence used CAM. Vitamin preparations (67%), mistletoe therapy (59%), and mineral preparations (33%) were used most frequently. 70% of the patients used a combination of two or more preparations/therapies. The most cited reason for using CAM was the aim of increasing quality of life (28%) and improving the immune system (27%). 72% stated an improvement of their individual perception. The main source of information was the general practitioner or the gynecologist. CONCLUSION: The radiotherapist has to take these complementary/alternative therapies into consideration; their importance should be evaluated in further studies.


Subject(s)
Breast Neoplasms/therapy , Carcinoma/therapy , Complementary Therapies/statistics & numerical data , Neoplasm Recurrence, Local/therapy , Adult , Aged , Breast Neoplasms/pathology , Carcinoma/secondary , Complementary Therapies/methods , Female , Health Knowledge, Attitudes, Practice , Humans , Middle Aged , Radiotherapy, Adjuvant
SELECTION OF CITATIONS
SEARCH DETAIL
...